His scientific interests lie mostly in Immunology, Antigen, T-cell receptor, Immune system and T cell. His Immunology study deals with Cell biology intersecting with Cytotoxic T cell. The concepts of his Antigen study are interwoven with issues in Vaccination, Cancer vaccine, Naked DNA and Cancer immunotherapy.
Paolo Dellabona studied T-cell receptor and T lymphocyte that intersect with Autoimmunity, Neuroimmunology, Experimental autoimmune encephalomyelitis, Myelin oligodendrocyte glycoprotein and Polyclonal antibodies. His Immune system research includes elements of Immunologic Technique, Immunophenotyping, Monoclonal antibody and Cytometry. His T cell study integrates concerns from other disciplines, such as Molecular biology and Immunological memory.
Paolo Dellabona mostly deals with Immunology, Antigen, Natural killer T cell, Molecular biology and Cell biology. In Immunology, Paolo Dellabona works on issues like Cytotoxic T cell, which are connected to Priming. His Antigen research is multidisciplinary, incorporating perspectives in Cell culture and Cancer research.
His Natural killer T cell research integrates issues from Acquired immune system and B cell. His research integrates issues of Transfection, Epitope, Antibody, Monoclonal antibody and In vivo in his study of Molecular biology. His Effector study in the realm of Cell biology connects with subjects such as Dicer.
Paolo Dellabona mainly investigates Immunology, Cancer research, Immunotherapy, CD1D and Natural killer T cell. His Immunology and Leukemia, Bone marrow, Human leukocyte antigen, CD1 and T cell investigations all form part of his Immunology research activities. His CD1 research is under the purview of Antigen.
His work deals with themes such as Oxidative stress, Regulatory T-cell apoptosis and Cell biology, which intersect with Antigen. Paolo Dellabona interconnects Mononuclear phagocyte system, Tissue homeostasis, Crosstalk and Endogeny in the investigation of issues within Natural killer T cell. His study looks at the intersection of Monoclonal antibody and topics like Cytometry with Immune system.
The scientist’s investigation covers issues in Immunology, Flow cytometry, Cell sorting, Immune system and CD1D. His study in Leukemia, Bone marrow and T cell falls under the purview of Immunology. His T cell research incorporates themes from Cancer cell and Somatic cell.
Paolo Dellabona works mostly in the field of Immune system, limiting it down to concerns involving Tumor progression and, occasionally, Cancer research. His Cancer research research includes elements of Epitope, Human leukocyte antigen, CD8 and Antigen. His CD1D study is focused on Natural killer T cell in general.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Guidelines for the use of flow cytometry and cell sorting in immunological studies
Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Mübeccel Akdis.
European Journal of Immunology (2017)
CD1d-mediated Recognition of an α-Galactosylceramide by Natural Killer T Cells Is Highly Conserved through Mammalian Evolution
Laurent Brossay;Mariacristina Chioda;Nicolas Burdin;Yasuhiko Koezuka.
Journal of Experimental Medicine (1998)
Laparoscopic Versus Open Colorectal Surgery: A Randomized Trial on Short-Term Outcome
Marco Braga;Andrea Vignali;Luca Gianotti;Walter Zuliani.
Annals of Surgery (2002)
Expression of two T cell receptor alpha chains: dual receptor T cells
Elisabetta Padovan;Giulia Casorati;Paolo Dellabona;Stefan Meyer.
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Andreas Acs.
European Journal of Immunology (2019)
Superantigens interact with MHC class II molecules outside of the antigen groove.
Paolo Dellabona;Jean Peccoud;Jean Peccoud;John Kappler;Philippa Marrack.
An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells.
Paolo Dellabona;Elisabetta Padovan;Giulia Casorati;Manfred Brockhaus.
Journal of Experimental Medicine (1994)
Melanoma Cells Present a MAGE-3 Epitope to CD4+ Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11
Simona Manici;Tiziana Sturniolo;Maria Adele Imro;Juergen Hammer.
Journal of Experimental Medicine (1999)
CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
Grazia Galli;Sandra Nuti;Simona Tavarini;Luisa Galli-Stampino.
Journal of Experimental Medicine (2003)
Invariant NKT cells sustain specific B cell responses and memory
Grazia Galli;Paola Pittoni;Elena Tonti;Carmine Malzone.
Proceedings of the National Academy of Sciences of the United States of America (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: